INVO Bioscience, Inc. (INVO)

1.3700 -0.1500 (-9.87%) At close: 04:00PM EDT

INVO Bioscience, Inc.

5582 Broadcast Court
Sarasota, FL 34240
United States
978 878 9505
https://www.invobio.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Steven M. Shum	CEO & Director	260k	N/A	1971
Mr. Andrea Goren	Chief Financial Officer	215k	N/A	1967
Mr. Michael Jos. Campbell	COO & VP of Business Development	220k	N/A	1958
Mr. Bojan Mitrovic Ph.D.	Director of Sales US	N/A	N/A	N/A
Mr. Robert Joseph Bowdring Jr.	Treasurer & Secretary	N/A	N/A	1958
Ms. Terah Krigsvold	Controller	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Florida.

Corporate governance

INVO Bioscience, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.